Loading...

RBC Lysis Buffer (10X)

Pricing & Availability
Regulatory Status
RUO
Other Names
Red blood cell lysis buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420301 100 mL 52€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
420302 500 mL 165€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Red Blood Cell (RBC) Lysis Buffer has been designed, formulated, and tested to ensure optimal lysis of RBCs in single cell suspensions with minimal effects on leukocytes. RBC Lysis Buffer is supplied as a 10X solution containing ammonium chloride, potassium carbonate, and EDTA, and should be diluted in deionized water prior to use. Nucleated RBCs are not effectively lysed with ammonium chloride. Test

Product Details
Technical data sheet

Product Details

Formulation
This red blood cell (RBC) lysis buffer is supplied as a 10X solution and should be diluted to 1X in deionized water. 100 ml of 10X concentrate will yield a quantity of 1X solution that is sufficient to lyse 500 samples.
Preparation
The pH of the 1X solution should fall within the range of pH 7.1-7.4. Adjust the pH if necessary. Warm the 1X solution to room temperature prior to use.
Storage & Handling
Store RBC lysis buffer between 2°C and 8°C.
Application Notes

A. Lysis of Mouse Spleen RBCs:
1. Harvest mouse spleen and prepare a single cell suspension.
2. Pellet the cells by centrifugation (350 x g); aspirate the supernatant.
3. Dilute the 10X Red Blood Cell Lysis Buffer to 1X working concentration with deionized water and resuspend the pellet in 5 ml of 1X Lysis Buffer.
4. Incubate on ice for 4-5 minutes with occasional shaking.
5. Stop the reaction by diluting the Lysis Buffer with 20-30 ml of 1X PBS.
6. Spin the cells (350 x g) and discard the supernatant.
7. Resuspend the pellet in the appropriate buffer (e.g., BioLegend Cell Staining Buffer Cat. No. 420201), wash 1X.
8. Count cells, adjust density, and proceed with cell staining procedures.
B. Lysis of Human Peripheral Blood RBCs:
1. Dilute the 10X RBC Lysis Buffer to 1X working concentration with deionized water. Warm the 1X solution to room temperature prior to use.
2. Add 2.0 ml of 1X RBC Lysis Buffer to each tube containing up to 100 µl of whole blood.
3. Gently vortex each tube immediately after adding the lysing solution. Incubate at room temperature, protected from light, for 10-15 minutes.
4. Centrifuge 350 x g for 5 minutes. Aspirate supernatant without disturbing pellet.
5. Resuspend the pellet in the appropriate buffer (e.g., BioLegend Cell Staining Buffer, Cat. No. 420201), wash 1X.
6. Resuspend and proceed with further procedures.

Application References

(PubMed link indicates BioLegend citation)
  1. Adams RA, et al. 2007. J. Exp. Med. 204:571.
  2. Feild-Corbett C, et al. 2009. Stem Cells. PubMed
  3. de Resende MM, et al. 2010. Physiol Genomics. 42:437. PubMed
  4. Roybal JD, et al. 2011. Mol Cancer Res. 9:25. PubMed
  5. Boldin MP, et al. 2011. J Exp Med. PubMed
  6. Kahlenberg JM, et al. 2011. J. Immunol. 187:6143. PubMed
  7. Deiuliis JA, et al. 2012. Am J Physiol Lung Cell Mol Physiol. 302:399. PubMed
  8. Wu CY, et al. 2012. PLoS One. 7:e42365. PubMed
  9. Hsia BJ, et al. 2012. J Allergy Clin Immunol. 130:205. PubMed
  10. Rico C, et al. 2012. Carcinogenesis. 33:2283. PubMed
  11. Jin J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2901. PubMed
  12. Saraiva AM, 2013. Hum Immunol. 74:207. PubMed
  13. Koon HW, et al. 2013. J Vis exp. 68:4208. PubMed
  14. Ma Dy, et al. 2013. J Virol. 87:3361. PubMed
  15. Han W, 2013. J. Immunol. 190:4786. PubMed
  16. Garcia-Acros I, et al. 2013. J Biol Chem. 288:14046. PubMed
  17. Zhao JL, et al. 2013. Elife. 21:537. PubMed
  18. Guo W, et al. 2013. J Gerontol A Biol Sci Med Sci. PubMed
  19. Yamasaki S, et al. 2013. Clin Vaccine immunol. 20:1508. PubMed
  20. Kraft P, et al. 2013. Stroke. 44:3202. PubMed
  21. Liu X, et al. 2013. Invest Ophthalmol Vis Sci. 54:7386. PubMed
  22. Fullerton AM, et al. 2013. Toxicol Sci. 136:72. PubMed
  23. Cekic C, et al. 2013. J Exp Med. 210:2693. PubMed
  24. Varga T, et al. 2013. J. Immunol. 191:5695. PubMed
  25. Ma Y, et al. 2014. Cancer Res. 74:436. PubMed
  26. Chang YJ, et al. 2014. Cytotherapy. 16:560. PubMed
  27. Kim MJ, et al. 2014. Mol Pharmacol. 86:284. PubMed
  28. Cekic C, et al. 2014. Cancer Res. 74:7250. PubMed
  29. Szulzewsky F, et al. 2015. PloS One. 10:116644. PubMed
Product Citations
  1. Barros-Martins J, et al. 2016. J Immunol. 196: 3642 - 3652. PubMed
  2. Dobie R, et al. 2020. Cell Reports. 29(7):1832-1847.e8.. PubMed
  3. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  4. Deiuliis J, et al. 2012. Am J Physiol Lung Cell Mol Physiol. 302:L399. PubMed
  5. Jin J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2901. . PubMed
  6. Rathakrishnan A, et al. 2020. Viruses. 12: . PubMed
  7. Wang Y, et al. 2021. Cancer Res. 81:384. PubMed
  8. Wang H, et al. 2022. Nat Biomed Eng. 6:882. PubMed
  9. Yeh PY, et al. 2022. Sens Actuators B Chem. 353: . PubMed
  10. Ammothumkandy A, et al. 2022. Nat Neurosci. 25:493. PubMed
  11. Melendez E, et al. 2022. Development. 149: . PubMed
  12. Argueta LB, et al. 2022. iScience. 25:104223. PubMed
  13. Wang S, et al. 2022. Adv Sci (Weinh). 9:e2201258. PubMed
  14. Meena AS, et al. 2022. Cell Rep. 39:110937. PubMed
  15. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  16. Sugimoto S, et al. 2022. Nat Metab. 4:775. PubMed
  17. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  18. Isildar B, et al. 2022. Inflamm Regen. 42:55. PubMed
  19. Xu Q, et al. 2022. Front Med (Lausanne). 9:940554. PubMed
  20. Alexandrou AT, et al. 2022. iScience. 25:105546. PubMed
  21. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  22. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  23. Tratwal J, et al. 2022. Front Endocrinol (Lausanne). 13:1001210. PubMed
  24. Xie Z, et al. 2022. Cell Discov. 8:133. PubMed
  25. Xiang X, et al. 2022. Medicine (Baltimore). 101:e32558. PubMed
  26. Yu Z, et al. 2023. Cancer Res. 83:700. PubMed
  27. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  28. Oh S, et al. 2023. Nat Biotechnol. :. PubMed
  29. Marritt KL, et al. 2023. Front Immunol. 13:1087991. PubMed
  30. He T, et al. 2023. Immun Inflamm Dis. 11:e759. PubMed
  31. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  32. Li XF, et al. 2023. J Exp Med. 220: . PubMed
  33. Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed
  34. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  35. Feng J, et al. 2022. Immunity. 55:405. PubMed
  36. Rustagi Y, et al. 2022. Diabetes. 71:1149. PubMed
  37. Guennoun R, et al. 2022. Cancers (Basel). 14:. PubMed
  38. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  39. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  40. Wakiyama H, et al. 2022. Cancer Immunol Res. 10:1386. PubMed
  41. Roweth HG, et al. 2022. Sci Adv. 8:eabo5224. PubMed
  42. Zhong J, et al. 2022. J Adv Res. 41:145. PubMed
  43. Yun HJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  44. Daum P, et al. 2023. Front Immunol. 13:991347. PubMed
  45. Rao D, et al. 2023. Eur J Immunol. 53:e2250258. PubMed
  46. Le DT, et al. 2023. iScience. 26:106059. PubMed
  47. Romo-Rodríguez R, et al. 2023. Arch Med Res. 54:197. PubMed
  48. Mabire M, et al. 2023. Nat Commun. 14:1830. PubMed
  49. MacPherson KP, et al. 2023. Front Cell Neurosci. 17:895017. PubMed
  50. Chen Z, et al. 2023. Nat Commun. 14:1839. PubMed
  51. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  52. Ramalingam P, et al. 2023. Nat Commun. 14:2018. PubMed
  53. Choi YJ, et al. 2023. Nat Commun. 14:2045. PubMed
  54. He Q, et al. 2023. Parasit Vectors. 16:139. PubMed
  55. Pattnaik A, et al. 2023. Vaccines (Basel). 11:. PubMed
  56. Mulcrone PL, et al. 2023. Sci Rep. 13:8436. PubMed
  57. Villalba N, et al. 2023. J Neuroinflammation. 20:127. PubMed
  58. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  59. Matsudaira T, et al. 2023. Commun Biol. 6:665. PubMed
  60. Sandovici I, et al. 2022. Dev Cell. 57:63. PubMed
  61. Zhou B, et al. 2020. Nat Immunol. 1.868055556. PubMed
  62. Tan J, et al. 2021. iScience. 24(8):102835. PubMed
  63. Asem M, et al. 2020. Cancer Res. 1156:80. PubMed
  64. Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed
  65. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  66. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  67. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  68. Nguyen, H. P., An, K., et al. 2025. Nat Biotechnol. 43(12),1979-1995. PubMed
  69. Jebbawi, F., Olomski, F., et al. 2025. Allergy. 80(12),3377-3390. PubMed
  70. Xu, L., Paine, A. C., et al. 2025. J Virol. 99(10),e0126125. PubMed
  71. Haykal, T., Yang, R., et al. 2025. Cancer Res. 85(24),4995-5014. PubMed
  72. Li, S., Wang, Y., et al. 2025. Signal Transduct Target Ther. 10(1),323. PubMed
  73. Huang, H., Li, S., et al. 2025. Sci Rep. 15(1),35547. PubMed
  74. Li, Q., de Oliveira Formiga, R., et al. 2025. Nat Metab. 7(12),2510-2530. PubMed
  75. Phoon, Y. P., Wolfarth, A. A., et al. 2025. Sci Rep. 15(1),37950. PubMed
  76. Choi, Y., Shim, M., et al. 2025. Exp Mol Med. 57(11),2487-2504. PubMed
  77. Chen, Y., Liao, Y., et al. 2025. Nat Commun. 16(1),10249. PubMed
  78. Han, C., Yuan, H., et al. 2025. FASEB J. 39(23),e71273. PubMed
  79. Wessel, B. M., Castro, J. N., et al. 2025. Organoids. 4(4),0. PubMed
  80. Qiu, Z., Song, N. J., et al. 2025. J Clin Invest. 0(0),0. PubMed
  81. Lu, W., Jin, T., et al. 2025. Sci Rep. 15(1),44077. PubMed
  82. Izgutdina, A., Rashid, T., et al. 2025. J Immunother Cancer. 13(12),0. PubMed
  83. Spengler J, et al. 2016. J Infect Dis. 214: S308 - S318. PubMed
  84. Zheng M, et al. 2016. J Immunol. 196: 4122 - 4131. PubMed
  85. St-Pierre S, et al. 2016. PLoS One. 11: 0150230. PubMed
  86. Ensan S, et al. 2015. Nat Immunol. 17: 159-168. PubMed
  87. Jaiswal M, et al. 2015. Sci Rep. 5: 15221. PubMed
  88. Hou J, et al. 2015. J Mol Cell Biol. 7: 338-350. PubMed
  89. Fujii H, et al. 2015. PLoS One. 10: 0133216. PubMed
  90. Herisson F, et al. 2018. Nat Neurosci. 21:1209. PubMed
  91. Pracht K, et al. 2021. Eur J Immunol. 51:1089. PubMed
  92. Radwanska M, et al. 2020. Methods Mol Biol. 2116:721. PubMed
  93. Rendon CJ, et al. 2022. Front Endocrinol (Lausanne). 13:995499. PubMed
  94. Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed
  95. Della Verde G, et al. 2022. Life Sci Alliance. 5:. PubMed
  96. Su C, et al. 2021. Front Oncol. 11:719564. PubMed
  97. Jacoby E, et al. 2021. NPJ Regen Med. 6:58. PubMed
  98. Chen Z, et al. 2020. Glia. 68:2148. PubMed
  99. Seow JJW, et al. 2021. Front Med (Lausanne). 8:603374. PubMed
  100. Shin J, et al. 2020. Hum Gene Ther. . PubMed
  101. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  102. Ma Y, et al. 2014. Cancer Res. 74:436. PubMed
  103. Magalhães L, et al. 2015. PLoS Negl Trop Dis. 10: 0003816. PubMed
  104. Moraes-Vieira P, et al. 2016. Diabetes. 65: 1317 - 1327. PubMed
  105. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  106. Wang J, et al. 2020. Sci Rep. 10:12785. PubMed
  107. Liu W, et al. 2017. Int J Environ Res Public Health. 10.3390/ijerph14060592. PubMed
  108. Pietrocola F, et al. 2017. Autophagy. 0.935416667. PubMed
  109. Bikorimana JP, et al. 2022. Cell Rep Med. 3:100534. PubMed
  110. Zhang L, et al. 2022. JCI Insight. 7:. PubMed
  111. Baldominos P, et al. 2022. STAR Protoc. 3:101795. PubMed
  112. Ma H, et al. 2021. Front Immunol. 12:760095. PubMed
  113. McGill CJ, et al. 2021. STAR Protoc. 2:100948. PubMed
  114. Lutze J, et al. 2022. Methods Mol Biol. 2394:299. PubMed
  115. Hosseini A, et al. 2022. Evid Based Complement Alternat Med. 2022:5639226. PubMed
  116. Garcia-Fabiani MB, et al. 2020. STAR Protoc. :1. PubMed
  117. Zhang J, et al. 2021. Aging (Albany NY). 13:17880. PubMed
  118. Press AT, et al. 2021. EMBO Mol Med. 13:e14436. PubMed
  119. Sima LE, et al. 2021. J Immunother Cancer. 9:. PubMed
  120. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  121. Brunmeir R, et al. 2016. PLoS Genet. 12:e1006474. PubMed
  122. Pridans C, et al. 2016. J Immunol. 197: 2297 - 2305. PubMed
  123. Mircheff A, et al. 2016. Ocul Surf. 14:460-483. PubMed
  124. Pennington L, et al. 2016. Nat Commun. 7:11610. PubMed
  125. Koon H, et al. 2012. J Vis Exp. 68: 4208. PubMed
  126. Boldin M, et al. 2011. J Exp Med. 208:1189. PubMed
  127. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  128. Bravo–San Pedro JM, et al. 2019. Cell Metab. 30:754. PubMed
  129. Clark EL, et al. 2017. PLoS Genet. 13:e1006997. PubMed
  130. Cantor JR, et al. 2017. Cell. 169:258. PubMed
  131. Ji WJ, et al. 2017. Cytometry B Clin Cytom. 92:371. PubMed
  132. Chen J, et al. 2022. Nat Commun. 13:6759. PubMed
  133. Wu Y, et al. 2021. Nat Biomed Eng. 5:1336. PubMed
  134. Meng S, et al. 2022. Exp Anim. . PubMed
  135. Kokkinopoulos I, et al. 2021. Sci Rep. 11:15759. PubMed
  136. Johnson CL, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H756. PubMed
  137. Stringhini M, et al. 2021. MAbs. 13:1868066. PubMed
  138. Devalaraja S, et al. 2020. Cell. 1098:180. PubMed
  139. Elisabeth Schrumpf, Xiaojun Jiang 2017. Physiol Rep. 10.14814/phy2.13117. PubMed
  140. Hamour S, et al. 2015. PLoS One. 10: 0136238. PubMed
  141. Bazett M, Haston M 2016. Sci Rep. 6:19189. PubMed
  142. Luo B, et al. 2016. J Neurosci. 36: 9590 - 9603. PubMed
  143. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  144. Sakamoto S, et al. 2020. OncoImmunology. 8(12):e1671760.. PubMed
  145. Rico C, et al. 2012. Carcinogenesis. 33:2283. PubMed
  146. Pokhrel RH, et al. 2022. Int J Mol Sci. 23:. PubMed
  147. Wang D, et al. 2021. Signal Transduct Target Ther. 6:376. PubMed
  148. Machado H, et al. 2021. PLoS Pathog. 17:e1009933. PubMed
  149. Yan X, et al. 2022. Int J Biol Sci. 18:585. PubMed
  150. Singh SS, et al. 2021. Eur J Med Chem. 216:113312. PubMed
  151. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  152. Zhai Z, et al. 2021. Medicine (Baltimore). 100:e26214. PubMed
  153. Hu D, et al. 2021. J Cell Mol Med. 25:2900. PubMed
  154. Jones N, et al. 2021. Nat Commun. 12:1209. PubMed
  155. Facchini M, et al. 2014. J Vis Exp. 85: 51019. PubMed
  156. Ilievski V, et al. 2015. PLoS One. 10: 0136502. PubMed
  157. Saraiva A, et al. 2013. Hum Immunol. 74:207. PubMed
  158. Vannini N, et al. 2019. Cell Stem Cell. 24:405. PubMed
  159. Jiang J, et al. 2018. Cancer Med. 3.504861111. PubMed
  160. Chen Z, et al. 2017. Cancer Res. 77:2266. PubMed
  161. Kim M, et al. 2017. Int J Mol Sci. 10.3390/ijms18061275. PubMed
  162. Mo L, et al. 2022. Front Oncol. 12:871489. PubMed
  163. Huang L, et al. 2021. J Cell Physiol. 236:7308. PubMed
  164. Whytock KL, et al. 2022. iScience. 25:104772. PubMed
  165. Neufeld L, et al. 2021. Sci Adv. 7:. PubMed
  166. Friedman G, et al. 2020. Nat Cancer. 1:692. PubMed
  167. Kumar A, et al. 2021. Part Fibre Toxicol. 18:43. PubMed
  168. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  169. Scherer SD, et al. 2021. Breast Cancer Res. 23:100. PubMed
  170. Jeong J, et al. 2021. Immune Netw. 21:e31. PubMed
  171. Sitaraman S, et al. 2021. JCI Insight. 6:. PubMed
  172. Orr AN, et al. 2021. Int J Mol Sci. 22:. PubMed
  173. Yamasaki S, et al. 2013. Clin Vaccine Immunol. 20:1508. PubMed
  174. Fukui R, et al. 2016. J Immunol. 196: 416 - 427. PubMed
  175. Rodriguez-Garcia M, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.72. PubMed
  176. Patil R, et al. 2019. J Biomed Opt. 24:1. PubMed
  177. Ongaro T, et al. 2020. Oncotarget. 3.026388889. PubMed
  178. Kahlenberg J, et al. 2011. J Immunol. 187:6143. PubMed
  179. Han W, et al. 2013. J Immunol. 190:4786. PubMed
  180. Wang K, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.016. PubMed
  181. Appelbe O, et al. 2017. J Control Release.. 10.1016/j.jconrel.2017.09.043. PubMed
  182. Tang J, et al. 2017. Proc Natl Acad Sci U S A. 114:E7441. PubMed
  183. Liccardi G, et al. 2019. Mol Cell. 73:413. PubMed
  184. Qin L, et al. 2022. Nat Commun. 13:6051. PubMed
  185. Escudero-Lara A, et al. 2022. Front Behav Neurosci. 16:946975. PubMed
  186. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  187. Deng J, et al. 2021. Breast Cancer Res Treat. 185:85. PubMed
  188. Vivanco Gonzalez N, et al. 2022. STAR Protoc. 3:101280. PubMed
  189. Kildisiute G, et al. 2021. Sci Adv. 7: . PubMed
  190. Schiferle EB, et al. 2021. Sci Adv. 7: . PubMed
  191. Devalaraja S, et al. 2020. STAR Protoc. 1:100188. PubMed
  192. Bigenwald C, et al. 2021. Nat Med. 27:851. PubMed
  193. Gingrich AA, et al. 2021. Front Immunol. 12:670309. PubMed
  194. Agrawal V, et al. 2016. J Leukoc Biol. 100: 261 - 274. PubMed
  195. Martínez-Muriana A, et al. 2020. Stem Cell Res Ther. 11:53. PubMed
  196. Pennig J, et al. 2019. Sci Rep. 9:17937. PubMed
  197. Wang B, et al. 2017. Stem Cell Res Ther.. 10.1186/s13287-017-0744-6. PubMed
  198. Anstine L,et al. 2017. J Am Heart Assoc.. 10.1161/JAHA.117.007097. PubMed
  199. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  200. Evans AK, et al. 2020. Neurobiol Dis. 146:105089. PubMed
  201. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  202. Choi JW, et al. 2020. PLoS One. 15:e0235518. PubMed
  203. Alban TJ, et al. 2020. Front Immunol. 1.285416667. PubMed
  204. Jiang S, et al. 2017. Toxicology Lett. 10.1016/j.toxlet.2017.03.015. PubMed
  205. Sci T 2013. Toxicol Sci. 136:72. PubMed
  206. Metz H, et al. 2016. Proc Natl Acad Sci U S A. 113: 8795 - 8800. PubMed
  207. Nwani NG, et al. 2019. Cancers (Basel). 0.806944444. PubMed
  208. Ramalingam P, et al. 2020. Nat Commun. 11:666. PubMed
  209. Garcia-Arcos I, et al. 2013. J Biol Chem. 288:14046. PubMed
  210. Elphinstone R, et al. 2017. Infect Immun. 10.1128/IAI.00371-17. PubMed
  211. Kernfeld EM, et al. 2018. Immunity. 48:1258. PubMed
  212. Beaudoin-Bussières G, et al. 2022. Cell Rep. 38:110368. PubMed
  213. Hu H, et al. 2021. Cancer Immunol Res. 9:1298. PubMed
  214. Zhong W, et al. 2022. Nat Commun. 13:4390. PubMed
  215. So EY, et al. 2021. Am J Physiol Cell Physiol. 321:C569. PubMed
  216. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  217. Cheng Q, et al. 2020. Nat Nanotechnol. 0.842361111. PubMed
  218. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  219. Alghamri MS, et al. 2020. Methods Enzymol. 632:215. PubMed
  220. Yu Z, et al. 2021. Front Oncol. 11:659251. PubMed
  221. Deng J, et al. 2021. Nat Cancer. 2:503. PubMed
  222. Lizotte P, et al. 2016. Sci Rep. 6:31745. PubMed
  223. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  224. Rosenbluth JM, et al. 2020. Nat Commun. 11:1711. PubMed
  225. Tavakol DN, et al. 2021. Curr Protoc. 1:e275. PubMed
  226. Ullah I, et al. 2021. Immunity. 54:2143. PubMed
  227. He Y, et al. 2021. Front Immunol. 12:641206. PubMed
  228. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  229. Ercoli G, et al. 2022. Clin Transl Immunology. 11:e1366. PubMed
  230. Meng YM, et al. 2021. Nat Commun. 12:6011. PubMed
  231. Zhu QY, et al. 2021. Nat Commun. 12:6624. PubMed
  232. Patel M, et al. 2021. Cancer Res. 81:3985. PubMed
  233. Shi X, et al. 2021. Nat Commun. 12:2547. PubMed
  234. Ramaswamy G, et al. 2017. Sci Rep. 10.1038/srep45140. PubMed
  235. Weber G, et al. 2015. Surgery. 158: 248-254. PubMed
  236. Jiang H, et al. 2016. Nat Med. 10.1038/nm.4123. PubMed
  237. Elgueta R, et al. 2016. J Immunol. 197: 3970 - 3981. PubMed
  238. Hang J, et al. 2019. Cancer Med. 1.254166667. PubMed
  239. Tan X, et al. 2019. Sci Rep. 2.7125. PubMed
  240. Lienemann PS, et al. 2020. Adv Sci (Weinh). 7:1903395. PubMed
  241. Zhao J, et al. 2013. Elife. 21:537. PubMed
  242. Wen J, et al. 2017. J Hematol Oncol. 10.1186/s13045-017-0489-9. PubMed
  243. Ahmad S,et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. . 10.1016/j.pnpbp.2017.10.001. PubMed
  244. Fidalgo MF, et al. 2022. Life Sci Alliance. 5:. PubMed
  245. Stirling ER, et al. 2022. J Immunother Cancer. 10:. PubMed
  246. Hills LB, et al. 2021. J Immunol. 206:89. PubMed
  247. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  248. Pace J, et al. 2022. J Biomed Opt. 27:. PubMed
  249. Pedicona F, et al. 2022. Sci Signal. 15:eabl7989. PubMed
  250. Sharma A, et al. 2020. Cell. 183(2):377-394.e21. PubMed
  251. Theurl I, et al. 2016. Nat Med. 10.1038/nm.4146. PubMed
  252. Schweppe RE, et al. 2019. Mol Cancer Res. 17:1036. PubMed
  253. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  254. Yang A, et al. 2018. Cancer Discov. 0.525. PubMed
  255. Rentsendorj A, et al. 2017. Brain Behav Immun. 10.1016/j.bbi.2017.08.019. PubMed
  256. Yan Q, et al. 2022. Clin Transl Med. 12:e1084. PubMed
  257. Zhai K, et al. 2021. Nat Cancer. 2:1136. PubMed
  258. Zhao D, et al. 2020. Cancer Discov. 10:1374. PubMed
  259. Castoldi F, et al. 2020. Cell Death Discov. 0.339583333. PubMed
  260. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  261. Morris C, et al. 2017. MBio. 10.1128/mBio.00036-17. PubMed
  262. Varga T, et al. 2013. J Immunol. 191:5695. PubMed
  263. Samuelson D, et al. 2016. J Immunol. 196: 2655 - 2665. PubMed
  264. Tsao P, et al. 2016. Proc Natl Acad Sci U S A. 113: 8242 - 8247. PubMed
  265. Soncini M, et al. 2016. Proc Natl Acad Sci U S A. 113: E6219 - E6227. PubMed
  266. Yang C, et al. 2016. Sci Rep. 6:34643. PubMed
  267. Yang YS, et al. 2020. Mol Ther Methods Clin Dev. 17:922. PubMed
  268. Gangwar RS, et al. 2020. Sci Rep. 10:14348. PubMed
  269. Dyck S, et al. 2018. J Neuroinflammation. 0.6875. PubMed
  270. Michelotti TC, et al. 2022. Front Cell Dev Biol. 10:1025240. PubMed
  271. Ren X, et al. 2022. STAR Protoc. 3:101818. PubMed
  272. Hollerbach A, et al. 2021. J Thromb Haemost. . PubMed
  273. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  274. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  275. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  276. Majumdar D, et al. 2021. Curr Protoc. 1:e216. PubMed
  277. Nowyhed H, et al. 2017. Sci Rep. 7:40273. PubMed
  278. De Domenico E, et al. 2020. STAR Protoc. 1:100233. PubMed
  279. Wang Z, et al. 2020. Cell Rep. 33:108472. PubMed
  280. Sadik A, et al. 2020. Cell. 1252:182. PubMed
  281. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  282. Ito T, et al. 2021. Nat Commun. 12:2232. PubMed
  283. Canali S, et al. 2017. Blood. 129(4):405-414. PubMed
  284. Shen X, et al. 2016. Sci Rep. 6:38778. PubMed
  285. Sauter K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G533 - G547. PubMed
  286. Song C, et al. 2015. Blood. 126: 1813 - 1822. PubMed
  287. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  288. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  289. Ramachandran P, et al. 2019. Nature. 575:512. PubMed
  290. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  291. Bowers J, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01221. PubMed
  292. Feng D, et al. 2022. Nat Commun. 13:5554. PubMed
  293. Saber M, et al. 2021. J Neurosci Res. 99:1136. PubMed
  294. Xiang Y, et al. 2022. Skelet Muscle. 12:19. PubMed
  295. Yamazaki T, et al. 2021. Oncoimmunology. 10:1962592. PubMed
  296. Zhang J, et al. 2020. Pain. 161:1381. PubMed
  297. Heim CE, et al. 2020. Nature Microbiology. 5(10):1271-1284. PubMed
  298. Kraft P, et al. 2013. Stroke. 44:3202. PubMed
  299. Kim M, et al. 2014. Mol Pharmacol. 86:284. PubMed
  300. Cekic C, et al. 2014. Cancer Res. 74:7250. PubMed
  301. Pankova D, et al. 2016. Mol Cancer Res. 14: 287 - 295. PubMed
  302. Ma D, et al. 2013. J Virol. 87:3361. PubMed
  303. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  304. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  305. Bichsel C, et al. 2017. Sci Rep. 10.1038/s41598-017-09928-1. PubMed
  306. James M, et al. 2017. J Nucl Med. . 10.2967/jnumed.117.189597. PubMed
  307. Annibaldi A, et al. 2018. Mol Cell. 69:566. PubMed
  308. Hill SJ, et al. 2018. Cancer Discov. 1.308333333. PubMed
  309. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  310. Xue X, et al. 2021. Cent Eur J Immunol. 46:191. PubMed
  311. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  312. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  313. Tulasi DY, et al. 2021. Cell Mol Gastroenterol Hepatol. 11:1437. PubMed
  314. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  315. Muñoz-Ruiz M, et al. 2016. Nat Immunol. 10.1038/ni.3424. PubMed
  316. Chang Y, et al. 2014. Cytotherapy. 16:560. PubMed
  317. Hsia B, et al. 2012. J Allergy Clin Immunol. 130:205. PubMed
  318. Resende M, et al. 2010. Physiol Genomics. 42:437. PubMed
  319. McLaughlin S, et al. 2019. Nat Commun. 3.795833333. PubMed
  320. Koury J, et al. 2019. PLoS One. 14:e0218670. PubMed
  321. Zhang Z, et al. 2017. Journal of Translational Medicine. 10.1186/s12967-017-1196-6. PubMed
  322. Li N, et al. 2022. Nat Commun. 13:7281. PubMed
  323. Soileau AM, et al. 2022. Vet Sci. 9:. PubMed
  324. McClellan BL, et al. 2022. STAR Protoc. 3:101357. PubMed
  325. Governa V, et al. 2022. Proc Natl Acad Sci U S A. 119. PubMed
  326. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  327. Mai CL, et al. 2021. Theranostics. 11:1059. PubMed
  328. Chen P, et al. 2021. Clin Transl Med. 11:e462. PubMed
  329. Peng X, et al. 2021. Stem Cell Res Ther. 198:12. PubMed
  330. Linder A, et al. 2020. EMBO J. 39:e105071. PubMed
  331. Guo W, et al. 2013. J Gerontol A Biol Sci Med Sci. . PubMed
  332. Liu Y, et al. 2015. Sci Rep. 5: 15134. PubMed
  333. Hodson D, et al. 2016. Proc Natl Acad Sci U S A. 113: 2039-2046. PubMed
  334. Munson D, et al. 2016. Proc Natl Acad Sci U S A. 113: 8272 - 8277. PubMed
  335. Mochizuki M,et al. 2017. J Am Heart Assoc. . 10.1161/JAHA.117.005920. PubMed
  336. Roh–Johnson M, et al. 2017. Dev Cell. 43:549. PubMed
  337. Müller C, et al. 2018. Elife. 7:e34985. PubMed
  338. Sobecki M, et al. 2022. Cell Stem Cell. 29:1459. PubMed
  339. Cordo' V, et al. 2022. Nat Commun. 13:1048. PubMed
  340. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  341. Denoth-Lippuner A, et al. 2021. Cell Stem Cell. 28:2020. PubMed
  342. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  343. Nagree MS, et al. 2022. EMBO Mol Med. 14:e14297. PubMed
  344. Ubellacker J, et al. 2017. Breast Cancer Res. 10.1186/s13058-017-0815-8. PubMed
  345. DU T, et al. 2020. Front Immunol. 1.571527778. PubMed
  346. Trial J, et al. 2020. Geroscience. . PubMed
  347. Yu H, et al. 2016. Sci Rep. 6:35190. PubMed
  348. Now H, Yoo J 2016. Cell Mol Immunol. 10.1038/cmi.2016.32. PubMed
  349. Bosma M, et al. 2016. Nat Commun. 7: 11314. PubMed
  350. YC S, SJ L 2015. Sci Rep. 5: 12578. PubMed
  351. Szulzewsky F, et al. 2015. PLoS One. 10:116644. PubMed
  352. Wu C, et al. 2012. PLoS One. 7:e42363. PubMed
  353. Denning W, et al. 2011. PLoS One. 6:e16897. PubMed
  354. Weaver J, et al. 2017. Part Fibre Toxicol. 10.1186/s12989-017-0206-4. PubMed
  355. Samuelson D, et al. 2017. PLoS Pathogens. 13(6):e1006426. PubMed
  356. Wong C, et al. 2017. J Immunol. 10.4049/jimmunol.1700397. PubMed
  357. Visweshwaran SP, et al. 2022. Front Cell Dev Biol. 10:1008898. PubMed
  358. Li Q, et al. 2022. Signal Transduct Target Ther. 7:222. PubMed
  359. Fielding C, et al. 2022. Nat Commun. 13:543. PubMed
  360. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  361. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
  362. Wu R, et al. 2020. J Immunother Cancer. 8:00. PubMed
  363. Cekic C, et al. 2013. J Exp Med. 210:2693. PubMed
  364. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  365. Roybal J, et al. 2011. Mol Cancer Res. 9:25. PubMed
  366. Shaashua L, et al. 2022. Nat Commun. 13:6513. PubMed
  367. Yeini E, et al. 2021. Nat Commun. 12:1912. PubMed
  368. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  369. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  370. Kucykowicz S, et al. 2022. STAR Protoc. 3:101356. PubMed
  371. Kim TW, et al. 2022. Mol Ther Oncolytics. 26:1. PubMed
  372. Kathania M, et al. 2022. Cell Rep. 40:111345. PubMed
  373. Barcia Durán JG, et al. 2021. Commun Biol. 4:406. PubMed
  374. Park HJ, et al. 2021. Int J Mol Sci. 22:. PubMed
  375. Cebrian-Silla A, et al. 2021. Elife. 10:. PubMed
  376. Wang X, et al. 2016. J Virol. 90: 10247 - 10258. PubMed
  377. Mohammed R, et al. 2016. Cell Rep. 14:760-771. PubMed
  378. Durward-Diioia M, et al. 2015. Infect Immun . 83: 4759 - 4771. PubMed
  379. Birnie K, et al. 2015. Mol Cancer Res. 13: 1106 - 1118. PubMed
  380. Liu X, et al. 2013. Invest Ophthalmol Vis Sci . 54:7386. PubMed
  381. Field-Corbett C, et al. 2009. Stem Cells. 27:662. PubMed
  382. Zeng Y, et al. 2019. FASEB J. 33:6596. PubMed
  383. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  384. Tomas C, et al. 2019. Sci Rep. 9:11464. PubMed
  385. Kim JK, et al. 2019. Bioengineering (Basel). 6:24. PubMed
  386. Alizadeh A, et al. 2018. J Neuroinflammation. 15:53. PubMed
  387. Guo P, et al. 2017. J Clin Invest. 127:4242. PubMed
  388. Tsai SC, et al. 2017. Biomicrofluidics. 11:034122. PubMed
  389. Roy IM, et al. 2021. Bio Protoc. 11:e4130. PubMed
  390. Alam A, et al. 2022. STAR Protoc. 3:101563. PubMed
  391. Xiang Y, et al. 2022. Exp Mol Med. 54:1011. PubMed
  392. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  393. Guo P, et al. 2022. Nat Cell Biol. 24:99. PubMed
  394. Wahane S, et al. 2021. Sci Adv. 7:. PubMed
  395. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  396. Huang N, et al. 2021. Nat Med. 27:892. PubMed
  397. Song X, et al. 2021. FEBS Open Bio. 11:2453. PubMed
  398. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  399. Erady C, et al. 2021. NPJ Genom Med. 6:04. PubMed
  400. de Silva S, et al. 2020. Cancer Immunol Res. 0.493055556. PubMed
  401. Wan C, et al. 2021. Cancer Res. 81:158. PubMed

Antigen Details

Cell Type
Tregs
Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 06.10.2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account